JPMorgan Chase & Co’s Neurogene NGNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$94.7K Sell
6,335
-80,643
-93% -$1.21M ﹤0.01% 4817
2025
Q1
$1.02M Sell
86,978
-394,023
-82% -$4.61M ﹤0.01% 3650
2024
Q4
$11M Buy
481,001
+476,418
+10,395% +$10.9M ﹤0.01% 2163
2024
Q3
$192K Buy
4,583
+184
+4% +$7.72K ﹤0.01% 4469
2024
Q2
$160K Buy
4,399
+4,389
+43,890% +$160K ﹤0.01% 4374
2024
Q1
$509 Hold
10
﹤0.01% 5702
2023
Q4
$194 Sell
10
-1
-9% -$19 ﹤0.01% 6013
2023
Q3
$178 Hold
11
﹤0.01% 5891
2023
Q2
$185 Hold
11
﹤0.01% 5732
2023
Q1
$0 Sell
11
-3,637
-100% ﹤0.01% 6021
2022
Q4
$37K Buy
3,648
+801
+28% +$8.12K ﹤0.01% 4820
2022
Q3
$36K Sell
2,847
-1,429
-33% -$18.1K ﹤0.01% 4786
2022
Q2
$88K Buy
4,276
+2,897
+210% +$59.6K ﹤0.01% 4687
2022
Q1
$52K Sell
1,379
-7,381
-84% -$278K ﹤0.01% 5002
2021
Q4
$845K Buy
8,760
+4,008
+84% +$387K ﹤0.01% 3783
2021
Q3
$688K Buy
4,752
+3,939
+485% +$570K ﹤0.01% 3801
2021
Q2
$151K Buy
813
+206
+34% +$38.3K ﹤0.01% 4613
2021
Q1
$150K Sell
607
-119
-16% -$29.4K ﹤0.01% 4550
2020
Q4
$205K Buy
726
+116
+19% +$32.8K ﹤0.01% 4136
2020
Q3
$144K Buy
610
+90
+17% +$21.2K ﹤0.01% 3896
2020
Q2
$173K Buy
520
+500
+2,500% +$166K ﹤0.01% 3728
2020
Q1
$5K Buy
+20
New +$5K ﹤0.01% 4526
2019
Q3
Sell
-2,390
Closed -$114K 4866
2019
Q2
$114K Sell
2,390
-4,521
-65% -$216K ﹤0.01% 3970
2019
Q1
$372K Sell
6,911
-2,857
-29% -$154K ﹤0.01% 3504
2018
Q4
$422K Sell
9,768
-4,277
-30% -$185K ﹤0.01% 3465
2018
Q3
$823K Buy
+14,045
New +$823K ﹤0.01% 3271
2018
Q2
Sell
-131
Closed -$37K 4807
2018
Q1
$37K Sell
131
-837
-86% -$236K ﹤0.01% 4244
2017
Q4
$228K Buy
+968
New +$228K ﹤0.01% 3625
2016
Q2
Sell
-85
Closed -$15K 4314
2016
Q1
$15K Buy
+85
New +$15K ﹤0.01% 3664